CAR-T cells to deliver engineered peptide antigens and reprogram antigen specific T cell responses against solid tumors.

2530Background: Neoantigen depleted malignancies such as colorectal cancer demonstrate primary resistance to immune checkpoint blockade, and solid tumors in general have shown resistance to chimeri...